このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
China Shineway Pharmaceutical Group 配当金
配当金 基準チェック /46
China Shineway Pharmaceutical Group配当を支払う会社であり、現在の利回りは7.21%で、収益によって十分にカバーされています。
主要情報
7.4%
配当利回り
33%
配当性向
業界平均利回り | 3.6% |
次回配当支払日 | n/a |
配当落ち日 | n/a |
一株当たり配当金 | n/a |
一株当たり利益 | HK$1.28 |
3年後の配当利回り予想 | 10.4% |
最近の配当金アップデート
China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461
Apr 26China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461
Mar 31China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118
Sep 01Recent updates
If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity
Jun 03Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461
Apr 26Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?
Apr 17China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461
Mar 31China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings
Mar 14Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?
Jan 29China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118
Sep 01We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Aug 03Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?
May 30We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Mar 07China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125
Sep 01China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 31China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.
Mar 11Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?
Feb 18Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?
Jan 31Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?
Jan 13What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?
Dec 25We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years
Nov 25決済の安定と成長
配当データの取得
安定した配当: 2877の配当金支払いは、過去10年間 変動性 が高かった。
増加する配当: 2877の配当金は過去10年間にわたって増加しています。
配当利回り対市場
China Shineway Pharmaceutical Group 配当利回り対市場 |
---|
セグメント | 配当利回り |
---|---|
会社 (2877) | 7.4% |
市場下位25% (HK) | 3.3% |
市場トップ25% (HK) | 7.9% |
業界平均 (Pharmaceuticals) | 3.6% |
3年後のアナリスト予想 (2877) | 10.4% |
注目すべき配当: 2877の配当金 ( 7.21% ) はHong Kong市場の配当金支払者の下位 25% ( 3.23% ) よりも高くなっています。
高配当: 2877の配当金 ( 7.21% ) はHong Kong市場の配当金支払者の上位 25% ( 7.77% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: 2877の 配当性向 ( 32.7% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。
株主配当金
キャッシュフローカバレッジ: 2877は合理的な 現金配当性向 ( 51.2% ) を備えているため、配当金の支払いはキャッシュフローによって賄われます。